Company snapshot
- Ticker
- CRSP
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $4.83B
- Currency
- USD
- Website
- https://www.crisprtx.com
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range…
Latest coverage
- Casgevy Starts Paying Off for CRISPR: Rapid Earnings Reaction
November 2, 2026